<DOC>
	<DOCNO>NCT01915173</DOCNO>
	<brief_summary>The purpose study investigate effect widely available counter supplement market heartburn symptom symptoms health-related quality life patient gastroesophageal reflux disease ( GERD ) . This study design pilot trial ass safety feasibility provide preliminary estimate effect size .</brief_summary>
	<brief_title>Response Supplement Placebo GERD</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Heartburn</mesh_term>
	<criteria>Adult human age 1880 . Fluency write spoken English . Heartburn symptoms 3 day per week past month . Individuals take proton pump inhibitor ( PPI ) H2 receptor blocker dose change within 2 week initial study visit . Individuals Crohns disease , systemic sclerosis , know active ulcer disease , gastric cancer , Barrett 's esophagitis Significant pain difficulty swallow Heavy alcohol use ( define &gt; 6 drinks/week woman &gt; 13 drinks/week men ) Concurrent pregnancy Dementia Uncontrolled psychiatric disease Individuals unable complete paper symptom diary 6 7 day prior baseline visit Subjects whose symptom predominantly dyspeptic heartburn reflux Subjects use homeopathy GI symptom receive constitutional homeopathic treatment within past 2 week Subjects take herbal product supplement GERD dyspepsia relate symptom ( include peppermint oil ) Subjects take &gt; 12 dos NSAIDS within prior 30 day ( aspirin â‰¤ 325 mg daily allow ) Subjects lactose intolerance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Gastroesophageal reflux disease ( GERD )</keyword>
	<keyword>Heartburn</keyword>
	<keyword>Dyspepsia</keyword>
</DOC>